In insulin-treated type 1 diabetes, canagliflozin increased diabetic ketoacidosis
- PMID: 27429314
- DOI: 10.7326/ACPJC-2016-165-2-002
In insulin-treated type 1 diabetes, canagliflozin increased diabetic ketoacidosis
Comment on
-
Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes.Diabetes Care. 2016 Apr;39(4):532-8. doi: 10.2337/dc15-1995. Diabetes Care. 2016. PMID: 26989182 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources